Home/Filings/4/0001213900-19-026850
4//SEC Filing

Vitolo Ottavio V. 4

Accession 0001213900-19-026850

CIK 0001553643other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 4:53 PM ET

Size

5.3 KB

Accession

0001213900-19-026850

Insider Transaction Report

Form 4
Period: 2019-12-19
Vitolo Ottavio V.
Chief Medical Officer
Transactions
  • Award

    Options to purchase common stock

    2019-12-19$43.47/sh+105,000$4,564,350105,000 total
    Exercise: $43.47Exp: 2029-12-19Common Stock (105,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.

Documents

1 file

Issuer

RELMADA THERAPEUTICS, INC.

CIK 0001553643

Entity typeother

Related Parties

1
  • filerCIK 0001736257

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:53 PM ET
Size
5.3 KB